Search
Sirpiglenastat
go.drugbank.com/drugs/DB17536InvestigationalIt is under investigation in clinical trial NCT04471415 (Study to Investigate DRP-104 in Adults With Advanced Solid Tumors).
Synonyms: L-norleucine, n-acetyl-l-tryptophyl-6-diazo-5-oxo-, 1-methylethyl ester, Propan-2-yl (2s)-2-((n-acetyl-l-tryptophyl)amino)-6-diazo-5-oxohexanoateZibrofusidic acid
go.drugbank.com/drugs/DB20799InvestigationalZibrofusidic acid is under investigation in clinical trial NCT00626795 (Efficacy, Safety, and Tolerability of TD1414 2% Cream in Impetigo and Secondarily Infected Traumatic Lesions (SITL)).
Evixapodlin
go.drugbank.com/drugs/DB21520InvestigationalEvixapodlin is under investigation in clinical trial NCT04049617 (Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Evixapodlin (Formerly GS-4224) in Participants With Advanced
Amperozide
go.drugbank.com/drugs/DB08927ExperimentalAlternatively, amperozide's main use lies in veterinary medicine, where it is typically employed to minimize aggression and stress in intensively farmed pigs. … Investigations regarding the use of the agent revolved primarily around its capability for treating schizophrenia in humans even though the drug was ultimately never clinically adopted for this indication
ASP-4058
go.drugbank.com/drugs/DB11819InvestigationalASP4058 has been used in trials studying Food Effect of ASP4058 and Pharmacokinetics of ASP4058.
Pritelivir
go.drugbank.com/drugs/DB11844InvestigationalPritelivir has been used in trials studying the prevention of HSV-2 and Genital Herpes.
P-BCMA-101
go.drugbank.com/drugs/DB17371InvestigationalP-BCMA-101 is an autologous CAR-T therapy developed using Poseida’s piggyBac platform technology.
AAV-RPE65
go.drugbank.com/drugs/DB18343ExperimentalAAV-RPE65 is an adenovirus associated viral vector serotype 5 containing the human RPE65 gene
WU-NK-101
go.drugbank.com/drugs/DB18350InvestigationalWU-NK-101 is an allogeneic CD3-depleted, CD56-enriched activated natural killer-cell product
PRG-A01
go.drugbank.com/drugs/DB18613InvestigationalPRG-A01 is a novel inhibitor of Cu, Zn-superoxide dismutase (SOD1) misfolding and aggregation.